Alzamend Neuro, Inc. · NASDAQ:ALZN
MILTON C. AULT, III reported a 11.20% stake in Alzamend Neuro, Inc. (Schedule 13D/A)
Event Sep 26, 2025 · Filed Sep 30, 2025
MILTON C. AULT, III reported a 11.20% stake in Alzamend Neuro, Inc., 429,687 shares, with active intent on Sep 26, 2025. Filed Sep 30, 2025 (Schedule 13D/A).
- Stake
- 11.20%
- Shares
- 429,687
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MILTON C. AULT, III | 11.20% | 429,687 |
| WILLIAM B. HORNE | 0.10% | 3,518 |
| HENRY C.W. NISSER | 0% | 926 |
| KENNETH S. CRAGUN | 0% | 1,111 |
| DAVID J. KATZOFF | 0.10% | 1,726 |
| HYPERSCALE DATA, INC. | 10.90% | 416,715 |
| AULT LENDING, LLC | 10.90% | 416,703 |
| AULT LIFE SCIENCES, INC. | 0.30% | 11,068 |
| AULT LIFE SCIENCES FUND, LLC | 0% | 61 |
Source
Related
- Alzamend Neuro, Inc.
- Ault Milton C III
- Alzamend Neuro, Inc. shareholders
- Schedule 13D/A · Ault Milton C III · Oct 7, 2025
- Schedule 13D/A · Ault Milton C III · Oct 3, 2025
- Schedule 13D/A · Ault Milton C III · Sep 25, 2025
- Schedule 13D/A · Ault Milton C III · Sep 23, 2025
- Schedule 13D/A · Ault Milton C III · Aug 1, 2025
- Form 4 · Ault Milton C III · Aug 31, 2026
- Form 4/A · Ault Milton C III · Aug 31, 2026
- Form 4 · Ault Milton C III · Apr 16, 2026